AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Grey Matters Health Inc.

$0.37 -$0.09 (-20.06%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.37
Day Range
$0.37$0.44
Year Range
$0.22$0.64
Market Cap
2M
AVG Volume
10.72K
Trailing/Forward PE
-/0.05
PEG ratio
-
Dividend Yield
-
Next Earnings Date
2026-12-18
Primary Exchange
Other OTCUS
Net Income (CAD)
-10M-7.5M-5M-2.5M02016201720182019202020212022202320242025
AGNPF Net Income (CAD) by year
PeriodNet Income (CAD)
2025-2M
2024-502.9K
2023-6.78M
2022-6.05M
2021-7.73M
2020-8.54M
2019-1.9M
2018-937.51K
2017-1.89M
2016-6.88M
Operating Income (CAD)
-10M-7.5M-5M-2.5M02016201720182019202020212022202320242025
AGNPF Operating Income (CAD) by year
PeriodOperating Income (CAD)
2025-1.69M
2024-2.39M
2023-5.13M
2022-6.06M
2021-10M
2020-8.52M
2019-1.91M
2018-948.09K
2017-1.44M
2016-2.93M
EBITDA (CAD)
-10M-7.5M-5M-2.5M02016201720182019202020212022202320242025
AGNPF EBITDA (CAD) by year
PeriodEBITDA (CAD)
2025-1.18M
2024-2.35M
2023-5.19M
2022-4.85M
2021-173.03K
2020-8.49M
2019-1.89M
2018-907.4K
2017-1.32M
2016-2.89M
Cash Flows (CAD)
-8M-6M-4M-2M02016201720182019202020212022202320242025
AGNPF Cash Flows (CAD) by year
PeriodCash Flows (CAD)
2025-1.16M
2024-2.79M
2023-2.61M
2022-3.06M
2021-7.95M
2020-6.71M
2019-1.84M
2018-616.51K
2017-1.31M
2016-1.54M
EPS (CAD)
-200-150-100-5002016201720182019202020212022202320242025
AGNPF EPS (CAD) by year
PeriodEPS (CAD)
2025-0.6
2024-0.44
2023-5.9
2022-8.6
2021-13.16
2020-20.85
2019-10.7
2018-8.2
2017-19.7
2016-160.7
Expenses (CAD)
-2.5M02.5M5M7.5M10MR&DSG&ACapex2016201720182019202020212022202320242025
AGNPF Expenses (CAD) by year
PeriodExpenses (CAD)
20251.68M
20242.5M
20235.3M
20226.2M
20218.18M
20208.62M
20191.97M
2018937.03K
20171.54M
20163.15M
Cash & Debt (CAD)
02M4M6M8M2016201720182019202020212022202320242025
AGNPF Cash & Debt (CAD) by year
PeriodCash & Debt (CAD)
2025176.38K
2024596.2K
2023125.08K
20221.41M
20212.41M
20206.12M
2019207.81K
20181.25M
20171.39M
20161.6M
Debt ratios
00.20.40.62019202020212022202320242025
AGNPF Debt ratios by year
PeriodDebt ratios
20250.01
20240.05
20230.01
20220.09
20210.21
20200.49
20190.03
Return on Capital
-600%-400%-200%0%2016201720182019202020212022202320242025
AGNPF Return on Capital by year
PeriodReturn on Capital
2025-74.27%
2024-23.19%
2023-460.02%
2022-107.64%
2021-84.84%
2020-69.86%
2019-38.12%
2018-68.64%
2017-118.98%
2016-323.96%
Shares Outstanding
01M2M3M4M2016201720182019202020212022202320242025
AGNPF Shares Outstanding by year
PeriodShares Outstanding
20253.43M
20242.41M
20231.55M
2022771.1K
2021670.4K
2020477.9K
2019189.4K
2018115K
2017109.5K
201682.8K
Book Value Per Share (CAD)
01020302016201720182019202020212022202320242025
AGNPF Book Value Per Share (CAD) by year
PeriodBook Value Per Share (CAD)
20250.79
20240.9
20230.95
20227.29
202113.6
202025.56
201926.25
201811.88
201714.51
201625.64
Total Assets (CAD)
05M10M15M2016201720182019202020212022202320242025
AGNPF Total Assets (CAD) by year
PeriodTotal Assets (CAD)
20254.87M
20243.94M
20234.19M
20228.14M
202110.14M
202012.82M
20195.34M
20181.42M
20171.64M
20162.27M
PE Ratio
46810med 6.76May 25Jun 25Jun 25Jul 25Jul 25Aug 25Aug 25
AGNPF PE Ratio by year
PeriodPE Ratio
Aug 257.23
Aug 256.76
Aug 256.75
Aug 256.55
Jul 256.73
Jul 255
Jul 255.5
Jul 256.67
Jun 257.89
Jun 256.78
Jun 258.38
Jun 259.42
May 257.8
Free Cash Flow Yield
-250%-200%-150%-100%-50%0%med -91.14%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
AGNPF Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-52.76%
Sep 26-46.31%
Aug 26-62.54%
Aug 26-69.45%
Aug 26-69.33%
Aug 26-73.43%
Jul 26-91.05%
Jul 26-76.72%
Jul 26-77.11%
Jul 26-68.57%
Jul 26-69.73%
Jun 26-93.53%
Jun 26-89.3%
Jun 26-52.16%
Jun 26-66.66%
May 26-72.63%
May 26-92.56%
May 26-89.12%
May 26-92.64%
May 26-93.89%
Apr 26-86.03%
Apr 26-74.55%
Apr 26-73.75%
Apr 26-87.28%
Mar 26-69.96%
Mar 26-88.84%
Mar 26-88.83%
Mar 26-89.89%
Feb 26-91.23%
Feb 26-86.65%
Feb 26-64.66%
Feb 26-68.05%
Jan 26-62.66%
Jan 26-71.73%
Jan 26-60.67%
Jan 26-54.55%
Jan 26-53.24%
Dec 25-39.08%
Dec 25-39.22%
Dec 25-38.62%
Dec 25-43.65%
Nov 25-59.76%
Nov 25-66.25%
Nov 25-58.73%
Nov 25-54.42%
Oct 25-53.82%
Oct 25-59.59%
Oct 25-54.95%
Oct 25-65.53%
Oct 25-59.58%
Sep 25-65.8%
Sep 25-56.44%
Sep 25-59.69%
Sep 25-69.11%
Aug 25-83.45%
Aug 25-152.45%
Aug 25-163.13%
Aug 25-163.23%
Aug 25-168.22%
Jul 25-163.84%
Jul 25-220.48%
Jul 25-200.47%
Jul 25-165.16%
Jun 25-139.67%
Jun 25-162.49%
Jun 25-131.46%
Jun 25-116.98%
May 25-141.36%
May 25-130.38%
May 25-108.91%
May 25-130.84%
May 25-134.28%
Apr 25-151.86%
Apr 25-131.76%
Apr 25-125.21%
Apr 25-122.41%
Mar 25-140.72%
Mar 25-120.01%
Mar 25-125.79%
Mar 25-126.91%
Feb 25-120.44%
Feb 25-116.67%
Feb 25-111.79%
Feb 25-101.96%
Jan 25-139.02%
Jan 25-151.04%
Jan 25-160.36%
Jan 25-134.21%
Jan 25-160.76%
Dec 24-175.14%
Dec 24-195.14%
Dec 24-177.77%
Dec 24-152.92%
Nov 24-150.91%
Nov 24-156.14%
Nov 24-150.05%
Nov 24-142.87%
Nov 24-148%
Oct 24-144.87%
Oct 24-150.7%
Price to Book
00.511.52med 0.96Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
AGNPF Price to Book by year
PeriodPrice to Book
Sep 261.57
Sep 261.79
Aug 260.97
Aug 260.87
Aug 260.87
Aug 260.82
Jul 260.66
Jul 260.79
Jul 260.78
Jul 260.88
Jul 260.87
Jun 260.65
Jun 260.68
Jun 261.16
Jun 260.91
May 260.83
May 260.55
May 260.57
May 260.55
May 260.54
Apr 260.59
Apr 260.69
Apr 260.69
Apr 260.59
Mar 260.73
Mar 260.58
Mar 260.58
Mar 260.57
Feb 260.47
Feb 260.5
Feb 260.66
Feb 260.63
Jan 260.69
Jan 260.6
Jan 260.71
Jan 260.79
Jan 260.81
Dec 251.1
Dec 251.1
Dec 251.11
Dec 250.98
Nov 251.28
Nov 251.15
Nov 251.3
Nov 251.41
Oct 251.42
Oct 251.28
Oct 251.39
Oct 251.17
Oct 251.28
Sep 251.16
Sep 251.35
Sep 251.28
Sep 251.11
Aug 250.92
Aug 251.38
Aug 251.29
Aug 251.29
Aug 251.25
Jul 251.28
Jul 250.95
Jul 251.05
Jul 251.27
Jun 251.5
Jun 251.29
Jun 251.6
Jun 251.79
May 251.49
May 251.28
May 251.53
May 251.28
May 251.24
Apr 251.1
Apr 251.27
Apr 251.33
Apr 251.36
Mar 251.19
Mar 251.39
Mar 251.33
Mar 251.32
Feb 251.39
Feb 251.1
Feb 251.15
Feb 251.26
Jan 250.93
Jan 250.85
Jan 250.8
Jan 250.96
Jan 250.8
Dec 240.74
Dec 240.66
Dec 240.72
Dec 240.84
Nov 240.85
Nov 240.88
Nov 240.92
Nov 240.97
Nov 240.93
Oct 240.95
Oct 240.92
Grey Matters Health Inc.
AGNPF
Stockpicker

Video analysis: AGNPF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AGNPF

Grey Matters Achieves Final Major Milestone; Receives Radioactive Materials License from State of Florida for its Flagship NovaScan Neuroimaging Clinics™ Location

globenewswire.com · 20 Aug 2026

Grey Matters Achieves Final Major Milestone; Receives Radioactive Materials License from State of Florida for its Flagship NovaScan Neuroimaging Clinics™ Location

VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has now received its Radioactive Materials License (RML) from the State of Florida for its flagship NovaScan Neuroimaging Clinics™ location (“NovaScan” or “NovaScan Clinic”) scheduled to open by September 30th in Davie, Florida.

Grey Matters Announces CAD $800K of Private Placement Equity Financing and Convertible Debentures

globenewswire.com · 20 Aug 2026

Grey Matters Announces CAD $800K of Private Placement Equity Financing and Convertible Debentures

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce a non-brokered private placement of equity for gross proceeds of CAD $500,000 (the “Equity Unit”) and a non-brokered private placement of convertible debentures for gross proceeds of CAD $300,000 from the sale of up to 300 units of unsecured convertible debentures (a “Debenture Unit”), for an aggregate total of CAD $800,000 together called (the “Offering”). Each Equity Unit, at an issue price of $.40, will consist of one Class A common share in the capital of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant").

Grey Matters Retains Nationally Recognized ProScan to Read Brain Images from its Flagship NovaScan Neuroimaging Clinics™ Location in Florida

globenewswire.com · 19 Aug 2026

Grey Matters Retains Nationally Recognized ProScan to Read Brain Images from its Flagship NovaScan Neuroimaging Clinics™ Location in Florida

VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a professional services agreement with ProScan Reading Services (“ProScan”), a division of nationally recognized ProScan Imaging, to read the neuro scans from its flagship NovaScan Neuroimaging ClinicsTM location (“NovaScan” or “NovaScan Clinic”) scheduled to open by September 30th in Davie, Florida. ProScan provides remote, off-site teleradiology interpretations for approximately 500 medical centers, hospitals, and imaging clinics worldwide.

Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.

globenewswire.com · 4 Aug 2026

Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.

VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it plans to open its flagship NovaScan Neuroimaging ClinicsTM location next month in Davie, Florida and conduct a brain PET scan of its first patient by September 30th, 2026.

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

globenewswire.com · 6 Jul 2026

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

globenewswire.com · 18 Jun 2026

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce an increase to its non-brokered private placement (the “Offering”), previously announced on April 22, 2026 and updated on May 25, 2026 and June 5, 2026 to $1,250,000 and the closing of the second and final tranche (the “Second Tranche”). Gross proceeds from the Second Tranche totalled CAD $750,000 from the sale of 1,875,000 units (the “Units”) at an issue price of CAD $0.40 per Unit.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.